Search results for: Adult Immunisation
Filter search results
Socio-Economic Value of Adult Immunisation Programmes
18 April 2024
…in childhood immunisation globally, the value of adult immunisation programmes often remains overlooked. Access to adult vaccinations is inconsistent across countries, with limited inclusion in routine immunisation schedules. The WHO’s…
Analysing Global Immunisation Expenditure
15 April 2025
…on immunisation contrasts with the value of immunisation Immunisation expenditure averages only 0.08% of GDP among analysed countries. This is low compared to healthcare spending, with mean immunisation expenditure being…
Adult vaccination programmes deliver socio-economic benefits up to 19 times initial investment, according to new report
18 April 2024
…immunisation can deliver socio-economic returns proportional to childhood immunisation programmes (2). Despite this, access to adult vaccination is inconsistent around the world, with limited inclusion in routine immunisation schedules. Professor…
Prevention pays off – so why aren’t we doing more of it?
5 June 2025
…on child immunisation delivery, but seem to be overlooking the value of adult immunisations. In the UK for example, the adult immunisation framework is limited to only 5 out of 18 possible…
OHE submission to the UK Parliamentary Inquiry on an Ageing Society
20 May 2025
…the following to achieve this end: While substantial progress has been made in childhood immunisation, the value of adult immunisation programmes often remains overlooked. The UK has a limited adult immunisation…
Do child QALYs = adult QALYs? Five reasons why they might not
4 February 2020
…adults. Then there’s the question of who should do the valuing. With adult health states, it’s adult members of the general public who complete these valuation tasks. But that is…
Assessing the Productivity Value of Vaccines in Health Technology Assessment: Worth a Shot?
17 September 2020
…lead to the undervaluation of immunisation programmes. In the long-term, this may have negative consequences on R&D incentives for vaccines and their inclusion in national immunisation programmes, with detrimental effects…
OHE’s submission for the DHSC’s next 10 years of planning
9 December 2024
…to communities? Prevention budgets: We have ample evidence that demonstrates prevention is cost-effective (3-4 times more than treatment), provides great societal value (e.g. adult immunisation provide 19x their cost in…
The broader economic benefits of COVID-19 vaccination
13 October 2025
…COVID-19 immunisation have become increasingly restrictive worldwide, predominantly focusing on older adults (≥65 years) and population groups at risk of severe outcomes, and largely exclude healthy working-age adults. Whereas the…